Attached files
file | filename |
---|---|
EX-32.1 - EXHIBIT 32.1 - ACELRX PHARMACEUTICALS INC | ex_232198.htm |
EX-31.2 - EXHIBIT 31.2 - ACELRX PHARMACEUTICALS INC | ex_232197.htm |
EX-31.1 - EXHIBIT 31.1 - ACELRX PHARMACEUTICALS INC | ex_232196.htm |
EX-21.1 - EXHIBIT 21.1 - ACELRX PHARMACEUTICALS INC | ex_232194.htm |
EX-10.18 - EXHIBIT 10.18 - ACELRX PHARMACEUTICALS INC | ex_232264.htm |
EX-10.17 - EXHIBIT 10.17 - ACELRX PHARMACEUTICALS INC | ex_232262.htm |
EX-4.1 - EXHIBIT 4.1 - ACELRX PHARMACEUTICALS INC | ex_232263.htm |
10-K - FORM 10-K - ACELRX PHARMACEUTICALS INC | acrx20201231_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the following Registration Statements:
(i) |
Registration Statement on Form S-8 (No. 333-239213) pertaining to the 2020 Equity Incentive Plan and Amended and Restated 2011 Employee Stock Purchase Plan, |
(ii) |
Registration Statements on Form S-8 (Nos. 333-230139, 333-223535, 333-216492, 333-202709, 333-194634 and 333-187206) pertaining to the 2011 Equity Incentive Plan, |
|
(iii) | Registration Statements on Form S-8 (Nos. 333-237195, 333-209998 and 333-180334) pertaining to the 2011 Equity Incentive Plan and 2011 Employee Stock Purchase Plan, | |
(iv) | Registration Statement on Form S-8 (No. 333-172409) pertaining to the 2006 Stock Plan, 2011 Equity Incentive Plan and 2011 Employee Stock Purchase Plan, and | |
(v) | Registration Statement on Form S-3 (No. 333-239156) |
of our report dated March 15, 2021 with respect to the consolidated financial statements and schedule of AcelRx Pharmaceuticals, Inc., which appears in this Annual Report on Form 10-K.
/s/ OUM & CO. LLP
San Francisco, California
March 15, 2021